Table 2.
Characteristics of Studies Included in the Meta-Analysis for Inflammatory Biomarker Levels in Children with ADHD.
| Studies | ADHD, n (male, %) | TD, n (male, %) | Med (%)a | Age (yrs), mean (SD), or age range | Country |
|---|---|---|---|---|---|
| Oades (2010) [98] | 21 (67) | 21 (95) | 0 | ADHD: 9.84 (1.4) TD: 11.0 (1.5) | Germany |
| Verlaet (2019) [99] | 57 (71) | 69 (65) | 0 | ADHD: 8.98 (1.75) TD: 8.37 (1.69) | NL |
| Darwish (2019) [100] | 60 (83) | 60 (68) | 0 | ADHD: 8.4 (1.28) TD: 8.73 (1.89) | Egypt |
| Chang (2020) [101] | 95 (86) | 21 (71) | 0 | ADHD: 9.32 (3.05) TD: 9.19 (2.96) | Taiwan |
Note ADHD attention deficit hyperactivity disorder, N number, NL Netherlands, SD standard deviation, TD typically developing youth, yrs years.
aIndicates % of ADHD medication use in ADHD group.